OPEN END TURBO OPTIONSSCHEIN LONG - AMGEN | Market Closed - BOERSE MUENCHEN 19:27:11 28/06/2024 BST | ||
| 7.92 EUR | +0.64% |
|
| Current month | +10.00% | ||
| 1 month | +17.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 7.92 | +0.64% |
| 27/06/24 | 7.87 | -2.11% |
| 26/06/24 | 8.04 | -7.16% |
| 25/06/24 | 8.66 | +4.97% |
| 24/06/24 | 8.25 | +6.87% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 07:27 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ9FTE |
| ISIN | DE000GZ9FTE4 |
| Date issued | 01/03/2023 |
| Strike | 227.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.21 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.71 € |
|---|---|
| Lowest since issue | 0.287 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
